Clinical Infectious Diseases Acceptance Rate

Oxford Academic and IDSA do not publish a stable official acceptance-rate figure for CID that is strong enough to use as a precise planning number.

What is stable is the journal model:

• the journal is clinically oriented, not just infection-oriented
• patient-care relevance matters heavily
• outbreak or urgent public-health work can move differently from ordinary submissions
• scope fit is tighter than many authors assume

That is the planning surface authors actually need.

Clinical Infectious Diseases is usually asking:

• does this paper have direct clinical infectious-disease relevance?
• would the results change diagnosis, management, or interpretation for clinicians?
• does the manuscript belong in a clinical ID flagship rather than a more basic, epidemiologic, or specialty venue?
• is the evidence mature enough to support the practical claim?

Those are the questions that matter more than an unofficial percentage.

For CID, the useful question is:

Would an infectious-disease clinician or guideline-minded reader actually change interpretation or practice because of this paper?

If yes, the journal is plausible. If no, the acceptance-rate discussion is mostly noise.

The common misses are:

• centering the page on an unofficial percentage estimate
• confusing interesting pathogen science with CID-level clinical fit
• submitting narrow single-center data without broader clinical meaning
• assuming outbreak keywords automatically create flagship-journal relevance

Those are fit problems before they are rate problems.

If you are deciding whether to submit, these pages are more useful than an unofficial rate:

• is Clinical Infectious Diseases a good journal
• Clinical Infectious Diseases submission guide
• Journal of Infectious Diseases
• how to choose a journal for your paper

Together, they tell you whether the paper is truly clinician-facing, whether a neighboring ID journal is cleaner, and whether the manuscript really deserves CID-level positioning.

In our pre-submission review work evaluating manuscripts targeting Clinical Infectious Diseases, three patterns generate the most consistent desk rejections. Each reflects the journal's standard: clinically actionable infectious-disease research with broad applicability to ID practice, not just technically sound infection science.

Descriptive single-center epidemiology without generalizable clinical consequence. Clinical Infectious Diseases describes its scope as "topics relevant to the clinician" and prioritizes practice-relevant findings. The failure pattern is a single-institution retrospective cohort study describing outcomes for patients with a specific infection, reporting institutional patterns in antimicrobial use, or documenting the clinical characteristics of a patient population seen at one hospital. These papers often have solid methods but fail the generalizability test. CID editors ask: would an ID clinician at a different institution change anything about how they manage patients based on these findings? Single-center data showing that your hospital's MRSA rates are 12%, or that your ventilator-associated pneumonia protocol produced good outcomes, does not answer a question that generalizes to practice elsewhere. These papers consistently get redirected to Open Forum Infectious Diseases or hospital-specific ID journals.

Pathogen science paper with clinical framing appended to the introduction. CID receives many submissions from microbiologists and infectious-disease researchers whose primary advance is in pathogen biology but who frame the abstract and introduction clinically. The failure pattern is a paper on antimicrobial resistance mechanism (efflux pump upregulation, carbapenemase characterization, biofilm formation), on virulence factor biology (toxin production, adhesin expression), or on within-host evolution during antibiotic treatment, where the clinical framing is in the introduction and discussion but the actual data are laboratory microbiology. CID editors are experienced ID clinicians who distinguish between "infection science" and "clinical practice research" immediately. Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, and PLOS Pathogens are appropriate homes for this work; submitting to CID produces fast desk rejections.

Outbreak report without generalizable clinical or public health learning. CID publishes outbreak reports when they teach something new. The failure pattern is an outbreak report that describes an outbreak, identifies the source, documents the investigation methodology, and reports the infection control measures taken, without demonstrating what the clinical or public health community should do differently going forward. An outbreak of a common pathogen (norovirus in a long-term care facility, influenza in a school) with no novel features, an unusual epidemiological pattern, or new transmission route does not generate generalizable learning. CID expects outbreak reports to contribute a new clinical presentation, an unexpected antimicrobial resistance pattern, a novel transmission mode, or evidence that changes standard guidance. Reports that confirm established infection control practice at a new location belong in Infection Control and Hospital Epidemiology or regional public health journals. A CID submission readiness check can assess whether the clinical or public health learning in your manuscript meets CID's standard before submission.

The honest answer to "what is the Clinical Infectious Diseases acceptance rate?" is that there is no strong official number you should treat as exact.

The useful answer is:

• yes, the journal is selective
• no, a guessed percentage is not the right planning tool
• use clinical consequence, patient-care relevance, and evidence maturity instead

If you want help checking whether the manuscript really reads like CID before submission, a CID submission readiness check is the best next step.

The acceptance rate at Clinical Infectious Diseases is only one dimension of selectivity. What matters more is where in the process papers are filtered. Most rejections at selective journals happen at the desk - the editor reads the abstract, cover letter, and first few paragraphs and decides whether to send the paper for external review. Papers that make it past the desk have substantially better odds.

For authors, this means the real question is not "what percentage of papers get accepted?" but "will my paper survive the desk screen?" The desk screen is about scope fit, novelty signal, and evidence maturity - not about statistical odds.

If you are considering Clinical Infectious Diseases, these specific steps improve your chances:

• Lead with the advance, not the method. The first paragraph of your abstract should state what changed in the field, not how you ran the experiment.

• Match the journal's scope precisely. Read the last 3 issues. If your paper's topic doesn't appear, the desk rejection risk is high.

• Include a cover letter that addresses fit. Name the specific reason this paper belongs at Clinical Infectious Diseases rather than a competitor.

• Ensure the data package is complete. Missing controls, weak statistics, or incomplete characterization are common desk-rejection triggers.

• Check formatting requirements. Trivial formatting errors signal carelessness to editors.

For Clinical Infectious Diseases, authors should expect:

These are approximate ranges. Actual timelines vary by manuscript complexity, reviewer availability, and whether revisions are needed.

The acceptance rate for Clinical Infectious Diseases does not distinguish between desk rejections and post-review rejections. A paper desk-rejected in 2 weeks and a paper rejected after 4 months of review both count the same. The rate also does not reveal how acceptance varies by article type, geographic origin, or research area within the journal's scope.

Acceptance rates cannot predict your individual odds. A strong paper with clear scope fit, complete data, and solid methodology has substantially better odds than the headline number suggests. A weak paper with methodology gaps will be rejected regardless of the journal's overall rate.

A CID submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.